Japanese Generic Finasteride and Dutasteride: Key Patient Facts

A laboratory microscope with blurred glass bottles containing blue liquid in the background.

Japan has approved generic versions of finasteride and dutasteride, deeming them therapeutically equivalent to the brand-name medications. The main decision usually comes down to which active ingredient best suits your hair loss needs. A doctor can clarify this choice after examining your scalp.

Contents

What is a generic medicine?

A generic medicine has the same active ingredient as an already approved original medicine. To obtain approval, the manufacturer must demonstrate that the body absorbs the generic at a similar rate and in a comparable amount.

Absorption studies examine a substance’s peak blood concentration and total exposure over time. A 12-year review of 2,070 single-dose studies of oral generics found average differences of 4.35% in peak concentration and 3.56% in total exposure.1

These averages represent a broad range of oral medications assessed in the United States, excluding hair loss pills and Japanese generics. The differences observed in those studies were negligible.

The active ingredient targets the same site in the body. Inactive ingredients may vary, which matters primarily if you have allergies or difficulty swallowing a specific pill.

A systematic review of cardiovascular medicines, a separate field from hair loss treatment, found no evidence that brand-name drugs worked better than generics. Although many published opinion pieces were more cautious in their tone, they still presented significant viewpoints.2

Finasteride and dutasteride: how they differ

Finasteride and dutasteride both reduce DHT, the hormone most closely associated with male pattern hair loss. However, they differ in how many forms of the DHT-producing enzyme they inhibit.

How the two medicines compare

Finasteride inhibits the type 2 enzyme that converts testosterone to DHT, while Dutasteride inhibits both type 1 and type 2 forms, resulting in a greater reduction in DHT levels.

A key distinction is the duration each medication stays in the body. Dutasteride has a half-life of approximately five weeks, which is the time required for the body to eliminate half of the drug.

AspectFinasterideDutasteride
How it lowers DHTBlocks the type 2 enzyme onlyBlocks both type 1 and type 2 enzymes
Hair effect in short comparisonsIncreases hair count compared with placeboShows greater early improvement than finasteride
How long it stays in the bodyClears more quicklyHas a half-life of about five weeks

What short-term research shows

In a 24-week randomized study of 917 men, dutasteride produced greater improvements in hair count, hair width, and frontal photo ratings than finasteride and placebo.3

In a meta-analysis of 15 double-blind trials, sexual side effects were more likely with these medicines than placebo, though not significantly for dutasteride alone, and a separate meta-analysis of three 24-week comparisons found no significant difference between the two.4,5

Some men experience sexual side effects that may persist after discontinuing these medications. Inform your prescribing doctor about any ongoing changes.

Dutasteride shows an advantage in 24-week comparisons. However, these studies do not indicate whether the effects last longer or apply universally to all patients.

How Japan reviews generic medicines

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) reviews generic medicines as part of its drug approval process. A generic medicine is not approved solely because the original product passed review.

The manufacturer must provide data demonstrating that the generic closely resembles the original enough to be considered therapeutically equivalent.

During the visit, you can review the active ingredient on the package, the product your clinic dispenses, and the schedule for monitoring progress.

Choosing a generic or brand-name pill

The choice between a generic and an original medication often matters less than the decision between finasteride and dutasteride. Our doctors prescribe both original and generic versions. Discuss with your doctor which product is best for you.

A generic medication is not necessarily weaker. If you have used a specific product without issues, your doctor can take that into account.

Points to confirm before you start

Discuss these points with your doctor, as each one could potentially change the treatment plan.

  • Which active ingredient fits your hair loss pattern
  • Any past reaction to a hair loss pill or another medicine
  • When to assess your progress, usually around six months after starting
  • Any PSA tests or family planning matters that could affect the choice

Both medications can reduce PSA levels, which is a marker used in prostate examinations. In a 48-week randomized study of men aged 40 to 60, finasteride lowered PSA by 40% to 50%.6 Please inform any doctor who orders that test that you are taking one of these medications.

At our clinics in Tokyo and Yokohama, our doctor will guide you through the options after conducting a scalp examination. Use the links below to learn more about our doctor or to contact our team.

Frequently asked questions

Are Japanese generic finasteride and dutasteride as effective as the brand-name versions?

Japan recognizes them as therapeutically equivalent to the originals. If you have previously tolerated a specific product, tell your doctor; otherwise, the active ingredient usually matters more.

Should I choose finasteride or dutasteride before my flight?

Wait until a doctor has examined your scalp, reviewed your health history, and discussed your plans for having children.

Finasteride blocks one form of the DHT-making enzyme, while dutasteride blocks both; short-term studies found larger early improvements with dutasteride, but that does not make it the automatic choice for every man.

During the visit, the doctor can discuss the trade-offs and schedule a follow-up to review your progress.

Will side effects differ between a generic and a brand-name pill?

The active ingredient remains the same, and the generic must demonstrate similar absorption levels before receiving approval. The main difference is the inactive ingredients. Inform the doctor about any previous allergies or reactions.

Do these pills affect other health checks?

Both finasteride and dutasteride can lower PSA results. Tell the doctor ordering the test if you are taking either medication. If you are planning to have children, mention this during the same visit.

References

1. Davit, B. M., Nwakama, P. E., Buehler, G. J., Conner, D. P., Haidar, S. H., Patel, D. T., Yang, Y., Yu, L. X., & Woodcock, J. (2009). Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. The Annals of Pharmacotherapy, 43(10), 1583-97. https://doi.org/10.1345/aph.1M141

2. Kesselheim, A. S., Misono, A. S., Lee, J. L., Stedman, M. R., Brookhart, M. A., Choudhry, N. K., & Shrank, W. H. (2008). Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA, 300(21), 2514-26. https://doi.org/10.1001/jama.2008.758

3. Gubelin Harcha, W., Barboza Martínez, J., Tsai, T. F., Katsuoka, K., Kawashima, M., Tsuboi, R., Barnes, A., Ferron-Brady, G., & Chetty, D. (2014). A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology, 70(3), 489-498.e3. https://doi.org/10.1016/j.jaad.2013.10.049

4. Zhou, Z., Song, S., Gao, Z., Wu, J., Ma, J., & Cui, Y. (2019). The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clinical Interventions in Aging, 14, 399-406. https://doi.org/10.2147/CIA.S192435

5. Lee, S., Lee, Y. B., Choe, S. J., & Lee, W. S. (2019). Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-venereologica, 99(1), 12-17. https://doi.org/10.2340/00015555-3035

6. D’Amico, A. V., & Roehrborn, C. G. (2007). Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. The Lancet. Oncology, 8(1), 21-5. https://doi.org/10.1016/S1470-2045(06)70981-0

Share this article
  • URL copied!
  • URL copied!
Contents